TGFB1 and plasma cell myeloma: In addition, a recent study demonstrated that armored BCMA CAR-T cells with dominant-negative TGF-β receptors resist TGF-β suppression, maintaining their cytotoxic function within the immunosuppressive myeloma microenvironment [125].